Merck

Merck, a leading science and technology company, has signed a non-binding Memorandum of Understanding (MoU) with Cyto-Facto Inc.,…

Merck’s Healthcare R&D, India has signed an MoU with JSS Academy of Higher Education & Research (JSS AHER), Mysuru,…

Merck, a leading science and technology company, and Tata Electronics Private Limited, a pioneering leader in India’s electronics…

According to GlobalData’s latest report, there is set to be a smaller proportion of global drug sales which will have patent…

At the Ahmedabad Pharma Summit 2025, Dr Shankar Varaganti, Commercial Marketing Manager, Merck, delivered a presentation on…

US pharma manufacturing sees investment surge amid tariff shifts, while BRICS nations push regulatory reforms to expand biosimilar…

Suneela Thatte highlighted that while the GCC was initially set up for cost savings in drug development, the focus has shifted to…

Merck faces setback as Keytruda combination trials fail to expand cancer treatment ahead of patent loss

Cladribine capsules have the potential to be the first oral treatment for gMG patients

When compared to patients in the control arm, patients in the vibostolimab and pembrolizumab fixed-dose combination arm…